Literature DB >> 24807733

Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification.

Annalisa Angelini1, Chiara Castellani, Marny Fedrigo, Onno J de Boer, Lorine B Meijer-Jorna, Xiaofei Li, Marialuisa Valente, Gaetano Thiene, Allard C van der Wal.   

Abstract

Cardiac allograft vasculopathy is regarded as a progressive and diffuse intimal hyperplastic lesion of arteries and veins that leads to insidious vessel narrowing and to allograft ischemic disease, such as acute myocardial infarction or sudden cardiac death. The coronary lesions in transplanted hearts are considered as a particular type of arteriosclerosis with many similarities but also significant differences compared to native coronary atherosclerosis. It is particularly difficult for pathologists to systematically classify the lesions and to elucidate their origins, since over time, the allograft immune responses cause vascular pathology characterized by not only the onset of de novo fibrocellular lesions but also remodeling of already-existing native atherosclerotic lesions in the donor heart. Intraplaque hemorrhages, which result from newly formed leaky microvessels, may cause rapid increase of stenosis and generate a substrate for plaque destabilization. Comparing cardiac allograft vasculopathy from explanted hearts at autopsy with native coronary atherosclerosis from hearts removed at transplantation has revealed that ongoing intraplaque hemorrhages are also an important feature of cardiac allograft vasculopathy and may be important factors in the rapid progression of cardiac allograft vasculopathy.

Entities:  

Mesh:

Year:  2014        PMID: 24807733     DOI: 10.1007/s00428-014-1586-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  60 in total

1.  Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy.

Authors:  Gerhard Poelzl; Robert Ullrich; Andreas Huber; Hanno Ulmer; Herwig Antretter; Daniel Hoefer; Thomas Mairinger; Guenther Laufer; Otmar Pachinger; Severin Schwarzacher
Journal:  Transpl Int       Date:  2005-03       Impact factor: 3.782

2.  Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.

Authors:  Li Dong; Williams S Kerwin; Huijun Chen; Baocheng Chu; Hunter R Underhill; Moni Blazej Neradilek; Thomas S Hatsukami; Chun Yuan; Xue-Qiao Zhao
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

Review 3.  Arteriosclerosis: rethinking the current classification.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Arch Pathol Lab Med       Date:  2009-08       Impact factor: 5.534

Review 4.  The implication of vasa vasorum in surgical diseases of the aorta.

Authors:  Nikolaos G Baikoussis; Efstratios E Apostolakis; Nikolaos A Papakonstantinou; Stavros N Siminelakis; Helen Arnaoutoglou; Georgios Papadopoulos; John Goudevenos; Dimitrios Dougenis
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-11       Impact factor: 4.191

5.  The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012.

Authors:  Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2012-10       Impact factor: 10.247

6.  The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.

Authors:  Jorg van Loosdregt; Matthijs F M van Oosterhout; Annette H Bruggink; Dick F van Wichen; Joyce van Kuik; Erica de Koning; Carla C Baan; Nicolaas de Jonge; Frits H J Gmelig-Meyling; Roel A de Weger
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

7.  Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease.

Authors:  P G Stovin; L D Sharples; P M Schofield; N R Cary; P A Mullins; T A English; J Wallwork; S R Large
Journal:  J Heart Lung Transplant       Date:  1993 Jan-Feb       Impact factor: 10.247

8.  Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis.

Authors:  Mark M Kockx; Kristel M Cromheeke; Michiel W M Knaapen; Johan M Bosmans; Guido R Y De Meyer; Arnold G Herman; Hidde Bult
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-23       Impact factor: 8.311

9.  Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression.

Authors:  Alida L P Caforio; Francesco Tona; Anna Belloni Fortina; Annalisa Angelini; Stefano Piaserico; Antonio Gambino; Giuseppe Feltrin; Angelo Ramondo; Marialuisa Valente; Sabino Iliceto; Gaetano Thiene; Gino Gerosa
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

10.  The spectrum of coronary artery pathologic findings in human cardiac allografts.

Authors:  D E Johnson; S Z Gao; J S Schroeder; W M DeCampli; M E Billingham
Journal:  J Heart Transplant       Date:  1989 Sep-Oct
View more
  5 in total

1.  Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Authors:  Kozo Okada; William F Fearon; Helen Luikart; Hideki Kitahara; Kyuhachi Otagiri; Shigemitsu Tanaka; Takumi Kimura; Paul G Yock; Peter J Fitzgerald; Alan C Yeung; Hannah A Valantine; Kiran K Khush; Yasuhiro Honda
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

2.  Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.

Authors:  Hideki Kitahara; Kozo Okada; Shigemitsu Tanaka; Hyoung-Mo Yang; Kojiro Miki; Yuhei Kobayashi; Takumi Kimura; Helen Luikart; Paul G Yock; Alan C Yeung; Peter J Fitzgerald; Kiran K Khush; William F Fearon; Yasuhiro Honda
Journal:  J Heart Lung Transplant       Date:  2016-03-10       Impact factor: 10.247

3.  Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients.

Authors:  Damien Vitiello; Diana Chaar; Paul-Eduard Neagoe; Anique Ducharme; Michel Carrier; Guy B Pelletier; Normand Racine; Mark Liszkowski; Martin G Sirois; Michel White
Journal:  Vasc Cell       Date:  2015-04-22

4.  The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis.

Authors:  Xiaohu Meng; Min Chen; Wenjie Su; Xuan Tao; Mingyang Sun; Xiaoping Zou; Rongchao Ying; Wei Wei; Baolin Wang
Journal:  Stem Cell Res Ther       Date:  2018-04-03       Impact factor: 6.832

Review 5.  Failing Heart Transplants and Rejection-A Cellular Perspective.

Authors:  Maria Hurskainen; Olli Ainasoja; Karl B Lemström
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.